Clinical trial for Chronic Hepatitis b
Official title Study of Tenofovir Alafenamide in HBV-Infected Pregnant Women
ClinicalTrials.gov ID: NCT05853718
What this study is testing
What is Tenofovir Alafenamide Tablets?
This is an investigational oral tablet being studied to help prevent the spread of hepatitis B from mother to baby during pregnancy. It is designed to lower the amount of hepatitis B virus in the blood by blocking the virus from copying itself.
Also referred to as TAF.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study looks at how the drug behaves in the body, how well it works, and its safety.
- Who it's for
- Pregnant women who have chronic hepatitis B.
- What's involved
- Participants will take the medication and have blood tests and visits to monitor the drug and health.
- Time commitment
- The study lasts during pregnancy and includes regular clinic visits.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40, women only
You may be able to join if
- Age of 20-40 years; Positive for hepatitis B surface antigen (HBsAg) and hepatitis B virus e antigen (HBeAg)
You likely can't join if
- Co-infected with hepatitis C or HIV, or other chronic diseases; History of spontaneous abortion or congenital malformation
The study team makes the final eligibility decision.
Where it is enrolling
- Hangzhou, Zhejiang, China
Compensation & support
A stipend or payment for your time may be offered.
No amount is published here because ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team, so confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hangzhou, Zhejiang, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.